These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 21275080)

  • 21. Plasma tryptophan, kynurenine and 3-hydroxykynurenine measurement using automated on-line solid-phase extraction HPLC-tandem mass spectrometry.
    de Jong WH; Smit R; Bakker SJ; de Vries EG; Kema IP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Mar; 877(7):603-9. PubMed ID: 19196554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maternal genotype determines kynurenic acid levels in the fetal brain: Implications for the pathophysiology of schizophrenia.
    Beggiato S; Notarangelo FM; Sathyasaikumar KV; Giorgini F; Schwarcz R
    J Psychopharmacol; 2018 Nov; 32(11):1223-1232. PubMed ID: 30354938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased cortical kynurenate content in schizophrenia.
    Schwarcz R; Rassoulpour A; Wu HQ; Medoff D; Tamminga CA; Roberts RC
    Biol Psychiatry; 2001 Oct; 50(7):521-30. PubMed ID: 11600105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Minor neurological and physical anomalies in patients with first-episode psychosis].
    Mhalla A; Boussaïd N; Gassab L; Gaha L; Mechri A
    Encephale; 2013 Jun; 39(3):149-54. PubMed ID: 23095597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early treatment-induced improvement of negative symptoms predicts cognitive functioning in treatment-naive first episode schizophrenia: a 2-year followup.
    Schuepbach D; Hill SK; Sanders RD; Hell D; Keshavan MS; Sweeney JA
    Schizophr Bull; 2004; 30(4):837-48. PubMed ID: 15957199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The kynurenine pathway in schizophrenia and bipolar disorder.
    Erhardt S; Schwieler L; Imbeault S; Engberg G
    Neuropharmacology; 2017 Jan; 112(Pt B):297-306. PubMed ID: 27245499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum concentrations of kynurenines in adult patients with attention-deficit hyperactivity disorder (ADHD): a case-control study.
    Aarsland TI; Landaas ET; Hegvik TA; Ulvik A; Halmøy A; Ueland PM; Haavik J
    Behav Brain Funct; 2015 Nov; 11(1):36. PubMed ID: 26542774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of inflammation on the kynurenine pathway in schizophrenia - a systematic review.
    Pedraz-Petrozzi B; Elyamany O; Rummel C; Mulert C
    J Neuroinflammation; 2020 Feb; 17(1):56. PubMed ID: 32061259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological manipulation of kynurenic acid: potential in the treatment of psychiatric disorders.
    Erhardt S; Olsson SK; Engberg G
    CNS Drugs; 2009; 23(2):91-101. PubMed ID: 19173370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma homovanillic acid levels and therapeutic outcome in schizophrenics: comparisons of neuroleptic-naive first-episode patients and patients with disease exacerbation due to neuroleptic discontinuance.
    Akiyama K; Tsuchida K; Kanzaki A; Ujike H; Hamamura T; Kondo K; Mutoh S; Miyanagi K; Kuroda S; Otsuki S
    Biol Psychiatry; 1995 Nov; 38(10):639-48. PubMed ID: 8555375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of different antipsychotics on cytokines and tryptophan metabolites in stimulated cultures from patients with schizophrenia.
    Krause D; Weidinger E; Dippel C; Riedel M; Schwarz MJ; Müller N; Myint AM
    Psychiatr Danub; 2013 Dec; 25(4):389-97. PubMed ID: 24247051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tryptophan-kynurenine and lipid related metabolites as blood biomarkers for first-episode drug-naïve patients with major depressive disorder: An exploratory pilot case-control study.
    Kuwano N; Kato TA; Setoyama D; Sato-Kasai M; Shimokawa N; Hayakawa K; Ohgidani M; Sagata N; Kubo H; Kishimoto J; Kang D; Kanba S
    J Affect Disord; 2018 Apr; 231():74-82. PubMed ID: 29454180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered serum levels of kynurenine metabolites in patients affected by cluster headache.
    Curto M; Lionetto L; Negro A; Capi M; Perugino F; Fazio F; Giamberardino MA; Simmaco M; Nicoletti F; Martelletti P
    J Headache Pain; 2015; 17(1):27. PubMed ID: 27000870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kynurenine pathway in psychosis: evidence of increased tryptophan degradation.
    Barry S; Clarke G; Scully P; Dinan TG
    J Psychopharmacol; 2009 May; 23(3):287-94. PubMed ID: 18562404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tryptophan breakdown pathway in bipolar mania.
    Myint AM; Kim YK; Verkerk R; Park SH; Scharpé S; Steinbusch HW; Leonard BE
    J Affect Disord; 2007 Sep; 102(1-3):65-72. PubMed ID: 17270276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New prospects for antipsychotic treatment - the role of the kynurenine pathway].
    Karakuła-Juchnowicz H; Flis M; Szymona K; Kuczyńska M; Stelmach E; Kowal-Popczak A
    Psychiatr Pol; 2014; 48(6):1167-77. PubMed ID: 25717486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ongoing episode of major depressive disorder is not associated with elevated plasma levels of kynurenine pathway markers.
    Dahl J; Andreassen OA; Verkerk R; Malt UF; Sandvik L; Brundin L; Ormstad H
    Psychoneuroendocrinology; 2015 Jun; 56():12-22. PubMed ID: 25770856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes.
    Doolin K; Allers KA; Pleiner S; Liesener A; Farrell C; Tozzi L; O'Hanlon E; Roddy D; Frodl T; Harkin A; O'Keane V
    Psychoneuroendocrinology; 2018 Sep; 95():8-17. PubMed ID: 29787958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of plasma cytokines on kynurenine and kynurenic acid in schizophrenia.
    Chiappelli J; Notarangelo FM; Pocivavsek A; Thomas MAR; Rowland LM; Schwarcz R; Hong LE
    Neuropsychopharmacology; 2018 Jul; 43(8):1675-1680. PubMed ID: 29520060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of indoleamine 2,3-dioxygenase expression and kynurenine pathway metabolites levels in serum samples of diabetic retinopathy patients.
    Munipally PK; Agraharm SG; Valavala VK; Gundae S; Turlapati NR
    Arch Physiol Biochem; 2011 Dec; 117(5):254-8. PubMed ID: 22034910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.